Terms: = Kidney tumors AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7 AND Treatment
13 results:
1. Genetic Differences Between Bladder and Upper Urinary Tract Carcinoma: Implications for Therapy.
Sfakianos JP; Gul Z; Shariat SF; Matin SF; Daneshmand S; Plimack E; Lerner S; Roupret M; Pal S
Eur Urol Oncol; 2021 Apr; 4(2):170-179. PubMed ID: 33386276
[TBL] [Abstract] [Full Text] [Related]
2. The first case of acute myeloid leukaemia/myeloid sarcoma with cytokeratin expression on blasts diagnosed on urine specimen.
Comerford C; Ni Mhaolcatha S; Hayes B; Mykytiv V
Hematol Oncol Stem Cell Ther; 2021 Dec; 14(4):343-347. PubMed ID: 32209310
[TBL] [Abstract] [Full Text] [Related]
3. Bilateral Wilms tumors: treatment results from a single center.
Aydın B; Akyüz C; Yalçın B; Ekinci S; Oğuz B; Akçören Z; Yıldız F; Varan A; Kurucu N; Büyükpamukçu M; Kutluk T
Turk J Pediatr; 2019; 61(1):44-51. PubMed ID: 31559721
[TBL] [Abstract] [Full Text] [Related]
4. [
Guo T; Dong X; Shi G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 49(4):551-555. PubMed ID: 30378308
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathologic Features of a Series of Primary Renal CIC-rearranged Sarcomas With Comprehensive Molecular Analysis.
Mangray S; Kelly DR; LeGuellec S; Fridman E; Aggarwal S; Shago M; Matoso A; Madison R; Pramanik S; Zhong S; Li R; Lombardo KA; Cramer S; Pressey J; Ross JS; Corona RJ; Bratslavsky G; Argani P; Coindre JM; Somers GR; Ali SM; Yakirevich E
Am J Surg Pathol; 2018 Oct; 42(10):1360-1369. PubMed ID: 29901569
[TBL] [Abstract] [Full Text] [Related]
6. [Survival analysis of surgically treated renal cell carcinoma: an analysis of 10-year data from single center].
Zhang YS; Yu HY; Dong F; Li HZ
Zhonghua Wai Ke Za Zhi; 2016 Jul; 54(7):528-33. PubMed ID: 27373480
[TBL] [Abstract] [Full Text] [Related]
7. Real-World Axitinib Use in the United States: A Retrospective Study Using Linked Datasets.
MacLean E; Cisar L; Mehle K; Eremina D; Quigley JM
J Manag Care Spec Pharm; 2016 Jun; 22(6):723-732u. PubMed ID: 27231799
[TBL] [Abstract] [Full Text] [Related]
8. Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation.
Wang J; Papanicolau-Sengos A; Chintala S; Wei L; Liu B; Hu Q; Miles KM; Conroy JM; Glenn ST; Costantini M; Magi-Galluzzi C; Signoretti S; Choueiri T; Gallucci M; Sentinelli S; Fazio VM; Poeta ML; Liu S; Morrison C; Pili R
Oncotarget; 2016 May; 7(21):29901-15. PubMed ID: 27144525
[TBL] [Abstract] [Full Text] [Related]
9. The mutational landscape of chromatin regulatory factors across 4,623 tumor samples.
Gonzalez-Perez A; Jene-Sanz A; Lopez-Bigas N
Genome Biol; 2013; 14(9):r106. PubMed ID: 24063517
[TBL] [Abstract] [Full Text] [Related]
10. Physical activity preferences in a population-based sample of kidney cancer survivors.
Trinh L; Plotnikoff RC; Rhodes RE; North S; Courneya KS
Support Care Cancer; 2012 Aug; 20(8):1709-17. PubMed ID: 21947412
[TBL] [Abstract] [Full Text] [Related]
11. Intensity-modulated radiation therapy for mesothelioma: impact of multileaf collimator leaf width and pencil beam size on planning quality and delivery efficiency.
Zhu XR; Prado K; Liu HH; Guerrero TM; Jeter M; Liao Z; Rice D; Forster K; Stevens CW
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1525-34. PubMed ID: 16029815
[TBL] [Abstract] [Full Text] [Related]
12. The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation.
Welsh SJ; Williams RR; Birmingham A; Newman DJ; Kirkpatrick DL; Powis G
Mol Cancer Ther; 2003 Mar; 2(3):235-43. PubMed ID: 12657718
[TBL] [Abstract] [Full Text] [Related]
13. The hrx proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures.
Butler LH; Slany R; Cui X; Cleary ML; Mason DY
Blood; 1997 May; 89(9):3361-70. PubMed ID: 9129043
[TBL] [Abstract] [Full Text] [Related]